kynurenine has been researched along with 2019 Novel Coronavirus Disease in 43 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The kynurenine and catecholamine metabolic pathways are modulated by inflammation and can affect systemic levels of serotonin and dopamine." | 8.31 | The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites. ( Bruckner, T; Deisenhammer, EA; Egeter, J; Galffy, M; Giesinger, JM; Gostner, JM; Holzner, B; Hüfner, K; Lehmann, J; Nelles, P; Oberhammer, M; Rockenschaub, J; Sacher, M; Sperner-Unterweger, B; Tymoszuk, P; Vedova, S, 2023) |
| "This study examines whether activation of the tryptophan catabolite (TRYCAT) pathway is associated with anxiety symptoms due to Long COVID." | 8.31 | Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway. ( Abed, AK; Al-Hakeim, HK; Almulla, AF; Maes, M; Rouf Moustafa, S, 2023) |
| " We review the literature concerning SARS-CoV2 infiltration and infection in the CNS and the prospects of synergy between stress, inflammation, and kynurenine pathway function during illness and recovery from Covid-19." | 5.12 | Covid-19 interface with drug misuse and substance use disorders. ( Cisneros, IE; Cunningham, KA, 2021) |
| " The kynurenine and catecholamine metabolic pathways are modulated by inflammation and can affect systemic levels of serotonin and dopamine." | 4.31 | The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites. ( Bruckner, T; Deisenhammer, EA; Egeter, J; Galffy, M; Giesinger, JM; Gostner, JM; Holzner, B; Hüfner, K; Lehmann, J; Nelles, P; Oberhammer, M; Rockenschaub, J; Sacher, M; Sperner-Unterweger, B; Tymoszuk, P; Vedova, S, 2023) |
| "This study examines whether activation of the tryptophan catabolite (TRYCAT) pathway is associated with anxiety symptoms due to Long COVID." | 4.31 | Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway. ( Abed, AK; Al-Hakeim, HK; Almulla, AF; Maes, M; Rouf Moustafa, S, 2023) |
| "Quinolinic acid (QA) is a metabolite of the kynurenine pathway, which is activated by inflammatory stimuli during viral infection." | 1.91 | The possible role of quinolinic acid as a predictive marker in patients with SARS-CoV-2. ( Baranyi, A; Enko, D; Herrmann, M; Meinitzer, A; Michaelis, S; Schnedl, WJ; Schneider, C; Zelzer, S, 2023) |
| " Bioavailability of tryptophan is an absolute requirement for proper cell functioning and synthesis of hormones, whereas its degradation products can cause cell death." | 1.72 | Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19. ( Bugiani, M; Dijkhuis, A; Duitman, JW; Geeraerts, Z; Guo, L; Lutter, R; Nossent, EJ; Roos, E; Schurink, B; van der Valk, P; van Vught, L; Vaz, FM; Vlaar, AP; Yeh, SR, 2022) |
| "Viral sepsis has been proposed as an accurate term to describe all multisystemic dysregulations and clinical findings in severe and critically ill COVID-19 patients." | 1.62 | Immunometabolic signatures predict risk of progression to sepsis in COVID-19. ( Borrego, JC; Castañeda-Delgado, JE; Enciso-Moreno, JA; Fernández-Ruiz, JC; Herrera-Van Oostdam, AS; López, JA; López-Hernández, Y; Mandal, R; Monárrez-Espino, J; Ochoa-González, F; Oropeza-Valdez, JJ; Soto-Guzmán, E; Trejo Medinilla, FM; Wishart, DS; Zhang, L; Zheng, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 43 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrera-Van Oostdam, AS | 1 |
| Castañeda-Delgado, JE | 1 |
| Oropeza-Valdez, JJ | 1 |
| Borrego, JC | 1 |
| Monárrez-Espino, J | 1 |
| Zheng, J | 1 |
| Mandal, R | 1 |
| Zhang, L | 1 |
| Soto-Guzmán, E | 1 |
| Fernández-Ruiz, JC | 1 |
| Ochoa-González, F | 1 |
| Trejo Medinilla, FM | 1 |
| López, JA | 1 |
| Wishart, DS | 1 |
| Enciso-Moreno, JA | 1 |
| López-Hernández, Y | 1 |
| D'Alessandro, A | 2 |
| Thomas, T | 2 |
| Akpan, IJ | 1 |
| Reisz, JA | 2 |
| Cendali, FI | 1 |
| Gamboni, F | 1 |
| Nemkov, T | 2 |
| Thangaraju, K | 1 |
| Katneni, U | 1 |
| Tanaka, K | 1 |
| Kahn, S | 1 |
| Wei, AZ | 1 |
| Valk, JE | 1 |
| Hudson, KE | 2 |
| Roh, D | 1 |
| Moriconi, C | 1 |
| Zimring, JC | 2 |
| Hod, EA | 2 |
| Spitalnik, SL | 2 |
| Buehler, PW | 1 |
| Francis, RO | 2 |
| Vyavahare, S | 1 |
| Kumar, S | 1 |
| Cantu, N | 1 |
| Kolhe, R | 1 |
| Bollag, WB | 1 |
| McGee-Lawrence, ME | 1 |
| Hill, WD | 1 |
| Hamrick, MW | 1 |
| Isales, CM | 1 |
| Fulzele, S | 1 |
| Fang, J | 1 |
| Feng, C | 1 |
| Chen, W | 1 |
| Hou, P | 1 |
| Liu, Z | 1 |
| Zuo, M | 1 |
| Han, Y | 1 |
| Xu, C | 1 |
| Melino, G | 1 |
| Verkhratsky, A | 1 |
| Wang, Y | 1 |
| Shao, C | 1 |
| Shi, Y | 1 |
| Jain, A | 2 |
| D'Amora, P | 1 |
| Silva, IDCG | 1 |
| Budib, MA | 1 |
| Ayache, R | 1 |
| Silva, RMS | 1 |
| Silva, FC | 1 |
| Appel, RM | 1 |
| Júnior, SS | 1 |
| Pontes, HBD | 1 |
| Alvarenga, AC | 1 |
| Arima, EC | 1 |
| Martins, WG | 1 |
| Silva, NLF | 1 |
| Diaz, RS | 1 |
| Salzgeber, MB | 1 |
| Palma, AM | 1 |
| Evans, SS | 1 |
| Nagourney, RA | 1 |
| Guo, L | 2 |
| Schurink, B | 1 |
| Roos, E | 1 |
| Nossent, EJ | 1 |
| Duitman, JW | 2 |
| Vlaar, AP | 1 |
| van der Valk, P | 1 |
| Vaz, FM | 2 |
| Yeh, SR | 1 |
| Geeraerts, Z | 1 |
| Dijkhuis, A | 2 |
| van Vught, L | 1 |
| Bugiani, M | 2 |
| Lutter, R | 2 |
| Lamperti, M | 1 |
| Doyle, DJ | 1 |
| Ansone, L | 1 |
| Briviba, M | 1 |
| Silamikelis, I | 1 |
| Terentjeva, A | 1 |
| Perkons, I | 1 |
| Birzniece, L | 1 |
| Rovite, V | 1 |
| Rozentale, B | 1 |
| Viksna, L | 1 |
| Kolesova, O | 1 |
| Klavins, K | 1 |
| Klovins, J | 1 |
| Michaelis, S | 3 |
| Zelzer, S | 3 |
| Schnedl, WJ | 3 |
| Baranyi, A | 3 |
| Meinitzer, A | 3 |
| Enko, D | 3 |
| Cihan, M | 1 |
| Doğan, Ö | 1 |
| Ceran Serdar, C | 1 |
| Altunçekiç Yıldırım, A | 1 |
| Kurt, C | 1 |
| Serdar, MA | 1 |
| Guarnieri, T | 1 |
| de Oliveira, JADP | 1 |
| de Athaide, MM | 1 |
| Rahman, AU | 1 |
| de Mattos Barbosa, MG | 1 |
| Jardim, MM | 1 |
| Moraes, MO | 1 |
| Pinheiro, RO | 1 |
| Mingoti, MED | 1 |
| Bertollo, AG | 1 |
| Simões, JLB | 1 |
| Francisco, GR | 1 |
| Bagatini, MD | 1 |
| Ignácio, ZM | 1 |
| Patel, K | 1 |
| Fernandez-Villamarin, M | 1 |
| Ward, C | 1 |
| Lord, JM | 1 |
| Tino, P | 1 |
| Mendes, PM | 1 |
| Dewulf, JP | 1 |
| Martin, M | 1 |
| Marie, S | 1 |
| Oguz, F | 1 |
| Belkhir, L | 1 |
| De Greef, J | 1 |
| Yombi, JC | 1 |
| Wittebole, X | 1 |
| Laterre, PF | 1 |
| Jadoul, M | 1 |
| Gatto, L | 1 |
| Bommer, GT | 1 |
| Morelle, J | 1 |
| Kucukkarapinar, M | 1 |
| Yay-Pence, A | 1 |
| Yildiz, Y | 1 |
| Buyukkoruk, M | 1 |
| Yaz-Aydin, G | 1 |
| Deveci-Bulut, TS | 1 |
| Gulbahar, O | 1 |
| Senol, E | 1 |
| Candansayar, S | 1 |
| Almulla, AF | 2 |
| Supasitthumrong, T | 1 |
| Tunvirachaisakul, C | 1 |
| Algon, AAA | 1 |
| Al-Hakeim, HK | 2 |
| Maes, M | 2 |
| Ceballos, FC | 1 |
| Virseda-Berdices, A | 1 |
| Resino, S | 1 |
| Ryan, P | 1 |
| Martínez-González, O | 1 |
| Peréz-García, F | 1 |
| Martin-Vicente, M | 1 |
| Brochado-Kith, O | 1 |
| Blancas, R | 1 |
| Bartolome-Sánchez, S | 1 |
| Vidal-Alcántara, EJ | 1 |
| Albóniga-Díez, OE | 1 |
| Cuadros-González, J | 1 |
| Blanca-López, N | 1 |
| Martínez, I | 1 |
| Martinez-Acitores, IR | 1 |
| Barbas, C | 1 |
| Fernández-Rodríguez, A | 1 |
| Jiménez-Sousa, MÁ | 1 |
| Saito, K | 1 |
| Ishikawa, R | 1 |
| Kitamura, I | 1 |
| Ogawa, K | 1 |
| Arakawa, N | 1 |
| Sun, Y | 1 |
| Imai, K | 1 |
| Maeda, T | 1 |
| Saito, Y | 1 |
| Hasegawa, C | 1 |
| Bizjak, DA | 1 |
| Stangl, M | 1 |
| Börner, N | 1 |
| Bösch, F | 1 |
| Durner, J | 1 |
| Drunin, G | 1 |
| Buhl, JL | 1 |
| Abendroth, D | 1 |
| Saheb Sharif-Askari, N | 1 |
| Soares, NC | 1 |
| Mohamed, HA | 1 |
| Saheb Sharif-Askari, F | 1 |
| Alsayed, HAH | 1 |
| Al-Hroub, H | 1 |
| Salameh, L | 1 |
| Osman, RS | 1 |
| Mahboub, B | 1 |
| Hamid, Q | 1 |
| Semreen, MH | 1 |
| Halwani, R | 1 |
| Schneider, C | 2 |
| Herrmann, M | 2 |
| Schuller, M | 3 |
| Oberhuber, M | 3 |
| Prietl, B | 3 |
| Zügner, E | 3 |
| Prugger, EM | 3 |
| Magnes, C | 3 |
| Kirsch, AH | 3 |
| Schmaldienst, S | 3 |
| Pieber, T | 3 |
| Brodmann, M | 3 |
| Rosenkranz, AR | 3 |
| Eller, P | 3 |
| Eller, K | 3 |
| Ruffieux, H | 1 |
| Hanson, AL | 1 |
| Lodge, S | 1 |
| Lawler, NG | 2 |
| Whiley, L | 2 |
| Gray, N | 2 |
| Nolan, TH | 1 |
| Bergamaschi, L | 1 |
| Mescia, F | 1 |
| Turner, L | 1 |
| de Sa, A | 1 |
| Pelly, VS | 1 |
| Kotagiri, P | 1 |
| Kingston, N | 1 |
| Bradley, JR | 1 |
| Holmes, E | 2 |
| Wist, J | 1 |
| Nicholson, JK | 2 |
| Lyons, PA | 1 |
| Smith, KGC | 1 |
| Richardson, S | 1 |
| Bantug, GR | 1 |
| Hess, C | 1 |
| Krčmová, LK | 1 |
| Matoušová, K | 1 |
| Javorská, L | 1 |
| Šmahel, P | 1 |
| Skála, M | 1 |
| Koblížek, V | 1 |
| Škop, J | 1 |
| Turoňová, D | 1 |
| Gančarčíková, M | 1 |
| Melichar, B | 1 |
| Cysique, LA | 1 |
| Jakabek, D | 1 |
| Bracken, SG | 1 |
| Allen-Davidian, Y | 1 |
| Heng, B | 1 |
| Chow, S | 1 |
| Dehhaghi, M | 1 |
| Staats Pires, A | 1 |
| Darley, DR | 1 |
| Byrne, A | 1 |
| Phetsouphanh, C | 1 |
| Kelleher, A | 1 |
| Dore, GJ | 1 |
| Matthews, GV | 1 |
| Guillemin, GJ | 1 |
| Brew, BJ | 1 |
| Hüfner, K | 1 |
| Vedova, S | 1 |
| Tymoszuk, P | 1 |
| Nelles, P | 1 |
| Bruckner, T | 1 |
| Deisenhammer, EA | 1 |
| Egeter, J | 1 |
| Galffy, M | 1 |
| Giesinger, JM | 1 |
| Lehmann, J | 1 |
| Oberhammer, M | 1 |
| Rockenschaub, J | 1 |
| Sacher, M | 1 |
| Holzner, B | 1 |
| Gostner, JM | 2 |
| Sperner-Unterweger, B | 1 |
| Badawy, AA | 2 |
| Appelman, B | 1 |
| Mooij-Kalverda, K | 1 |
| Houtkooper, RH | 1 |
| van Weeghel, M | 1 |
| Dekker, T | 1 |
| Smids, BS | 1 |
| Brinkman, P | 1 |
| Sikkens, JJ | 1 |
| Lavell, HAA | 1 |
| Wüst, RCI | 1 |
| van Vugt, M | 1 |
| Abed, AK | 1 |
| Rouf Moustafa, S | 1 |
| Rus, CP | 1 |
| de Vries, BEK | 1 |
| de Vries, IEJ | 1 |
| Nutma, I | 1 |
| Kooij, JJS | 1 |
| Stefanoni, D | 1 |
| Bertolone, L | 1 |
| Hansen, KC | 1 |
| Turski, WA | 1 |
| Wnorowski, A | 1 |
| Turski, GN | 1 |
| Turski, CA | 1 |
| Turski, L | 1 |
| Robertson, J | 1 |
| Nilsson, S | 1 |
| Andersson, LM | 1 |
| Fuchs, D | 1 |
| Gisslen, M | 1 |
| Lionetto, L | 1 |
| Ulivieri, M | 1 |
| Capi, M | 1 |
| De Bernardini, D | 1 |
| Fazio, F | 1 |
| Petrucca, A | 1 |
| Pomes, LM | 1 |
| De Luca, O | 1 |
| Gentile, G | 1 |
| Casolla, B | 1 |
| Curto, M | 1 |
| Salerno, G | 1 |
| Schillizzi, S | 1 |
| Torre, MS | 1 |
| Santino, I | 1 |
| Rocco, M | 1 |
| Marchetti, P | 1 |
| Aceti, A | 1 |
| Ricci, A | 1 |
| Bonfini, R | 1 |
| Nicoletti, F | 1 |
| Simmaco, M | 1 |
| Borro, M | 1 |
| Collier, ME | 1 |
| Zhang, S | 1 |
| Scrutton, NS | 1 |
| Giorgini, F | 1 |
| Kimhofer, T | 1 |
| Boughton, B | 1 |
| Gay, M | 1 |
| Yang, R | 1 |
| Morillon, AC | 1 |
| Chin, ST | 1 |
| Ryan, M | 1 |
| Begum, S | 1 |
| Bong, SH | 1 |
| Coudert, JD | 1 |
| Edgar, D | 1 |
| Raby, E | 1 |
| Pettersson, S | 1 |
| Richards, T | 1 |
| Marín-Corral, J | 1 |
| Rodríguez-Morató, J | 1 |
| Gomez-Gomez, A | 1 |
| Pascual-Guardia, S | 1 |
| Muñoz-Bermúdez, R | 1 |
| Salazar-Degracia, A | 1 |
| Pérez-Terán, P | 1 |
| Restrepo, MI | 1 |
| Khymenets, O | 1 |
| Haro, N | 1 |
| Masclans, JR | 1 |
| Pozo, OJ | 1 |
| Qin, WH | 1 |
| Liu, CL | 1 |
| Jiang, YH | 1 |
| Hu, B | 1 |
| Wang, HY | 1 |
| Fu, J | 1 |
| Cisneros, IE | 1 |
| Cunningham, KA | 1 |
10 reviews available for kynurenine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Tryptophan-Kynurenine Pathway in COVID-19-Dependent Musculoskeletal Pathology: A Minireview.
Topics: Animals; Bone Diseases; COVID-19; Humans; Kynurenine; Muscular Diseases; Receptors, Aryl Hydrocarbon | 2021 |
Redressing the interactions between stem cells and immune system in tissue regeneration.
Topics: Animals; Cell Adhesion Molecules; Cell Differentiation; Cell Proliferation; COVID-19; Humans; Immune | 2021 |
Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation.
Topics: Adaptive Immunity; Amino Acid Transport Systems, Neutral; Angiotensin-Converting Enzyme 2; Basic Hel | 2022 |
Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19.
Topics: COVID-19; Humans; Kynurenine; Leprosy; Peripheral Nervous System Diseases; SARS-CoV-2; Tryptophan | 2022 |
COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route.
Topics: COVID-19; Depression; Depressive Disorder, Major; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infl | 2022 |
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis.
Topics: COVID-19; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Tryptophan | 2022 |
AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
Topics: Air Pollutants; Betacoronavirus; Calcitriol; Coronavirus Infections; COVID-19; COVID-19 Drug Treatme | 2020 |
Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.
Topics: Basic Helix-Loop-Helix Transcription Factors; Betacoronavirus; Cell Line; Coronavirus Infections; CO | 2020 |
Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
Topics: Animals; Cognition; COVID-19; Humans; Inflammation; Kynurenine; Kynurenine 3-Monooxygenase; Neuropro | 2021 |
Covid-19 interface with drug misuse and substance use disorders.
Topics: Adaptation, Psychological; Angiotensin-Converting Enzyme 2; Animals; Axons; Comorbidity; COVID-19; D | 2021 |
33 other studies available for kynurenine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
Topics: Adult; Area Under Curve; Chemokines; COVID-19; Cytokines; Female; Humans; Kynurenine; Lymphocytes; M | 2021 |
Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19.
Topics: Acute Disease; Adult; Amino Acids; Body Mass Index; Carnitine; Cohort Studies; COVID-19; Fatty Acids | 2021 |
Deregulated kynurenine metabolism - An alternate hypothesis for COVID-19 associated anosmia.
Topics: Anosmia; COVID-19; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; SARS-CoV-2; Tryptophan | 2021 |
Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
Topics: Adult; Aged; Area Under Curve; Carnitine; Citrulline; COVID-19; Female; Glutamic Acid; Humans; Kynur | 2021 |
Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.
Topics: 3-Hydroxyanthranilic Acid; Adult; Aged; Apoptosis; Autopsy; Brain; COVID-19; Humans; Indoleamine-Pyr | 2022 |
COVID-19, perioperative neurocognitive disorder and SARS-CoV-2-induced dysregulation of the renin-angiotensin system and kynurenine metabolism. Comment on Br J Anaesth 2021; 127: e113-e115.
Topics: COVID-19; Humans; Kynurenine; Neurocognitive Disorders; Renin-Angiotensin System; SARS-CoV-2 | 2022 |
Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Topics: Amino Acids; Biomarkers; COVID-19; Hospitals; Host Microbial Interactions; Humans; Kynurenine; Metab | 2021 |
Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2.
Topics: COVID-19; Humans; Kynurenine; Prognosis; SARS-CoV-2; Tryptophan | 2022 |
Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
Topics: Adult; Aged; COVID-19; Female; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Picolinic Acid | 2022 |
Establishing a quantitative fluorescence assay for the rapid detection of kynurenine in urine.
Topics: Chromatography, High Pressure Liquid; COVID-19; Humans; Kynurenine | 2022 |
Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19.
Topics: Biomarkers; Chromatography, Liquid; COVID-19; Humans; Inflammation; Kynurenine; Metabolomics; SARS-C | 2022 |
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
Topics: Anxiety; Biomarkers; COVID-19; Depression; Humans; Kynurenic Acid; Kynurenine; Survivors; Tryptophan | 2022 |
Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.
Topics: COVID-19; Cross-Sectional Studies; Cytokines; Disease Progression; Female; Humans; Kynurenine; Male; | 2022 |
Characterization of serotonin as a candidate biomarker of severity and prognosis of COVID-19 using LC/MS analysis.
Topics: Biomarkers; Chromatography, Liquid; COVID-19; Humans; Kynurenine; Mass Spectrometry; Prognosis; Sero | 2022 |
Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; COVID-19 Testi | 2022 |
Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Topics: Aminolevulinic Acid; Biomarkers; C-Reactive Protein; Chromatography, Liquid; COVID-19; Humans; Kynur | 2022 |
Alteration of the kynurenine pathway is inversely associated with the humoral immune response in patients with SARS-CoV-2.
Topics: COVID-19; Humans; Immunity, Humoral; Kynurenine; SARS-CoV-2; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Topics: COVID-19; Humans; Kynurenine; Lipids; Renal Dialysis; Tryptophan | 2022 |
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection.
Topics: COVID-19; Humans; Kynurenine; Patient-Centered Care; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2023 |
Neopterin and kynurenine in serum and urine as prognostic biomarkers in hospitalized patients with delta and omicron variant SARS-CoV-2 infection.
Topics: Biomarkers; COVID-19; Humans; Kynurenine; Neopterin; Oxygen; Prognosis; SARS-CoV-2; Tryptophan | 2023 |
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC.
Topics: Adult; Biomarkers; Cognitive Dysfunction; COVID-19; Female; Humans; Kynurenine; Male; Middle Aged; P | 2023 |
The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites.
Topics: COVID-19; Cross-Sectional Studies; Dopamine; Humans; Inflammation; Kynurenine; Mental Health; Phenyl | 2023 |
The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy.
Topics: COVID-19; Humans; Immunotherapy; Kynurenine; NAD; Poly(ADP-ribose) Polymerase Inhibitors; SARS-CoV-2 | 2023 |
Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection.
Topics: Chromatography, Liquid; COVID-19; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukocyt | 2023 |
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway.
Topics: Anxiety; COVID-19; Humans; Kynurenine; Post-Acute COVID-19 Syndrome; Tryptophan | 2023 |
The possible role of quinolinic acid as a predictive marker in patients with SARS-CoV-2.
Topics: C-Reactive Protein; COVID-19; Humans; Kynurenine; Procalcitonin; Quinolinic Acid; SARS-CoV-2; Trypto | 2023 |
Treatment of 95 post-Covid patients with SSRIs.
Topics: COVID-19; Fatigue Syndrome, Chronic; Humans; Kynurenine; Primary Dysautonomias; Selective Serotonin | 2023 |
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.
Topics: Adult; Aged; Amino Acids; Betacoronavirus; Blood Glucose; Case-Control Studies; Coronavirus Infectio | 2020 |
Serum neopterin levels in relation to mild and severe COVID-19.
Topics: Adult; Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Kynurenine; Male; | 2020 |
Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study.
Topics: Aged; Biomarkers; COVID-19; Female; Humans; Kynurenine; Lymphocyte Count; Male; Middle Aged; SARS-Co | 2021 |
Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
Topics: Amines; COVID-19; Cytokines; Humans; Kynurenine; SARS-CoV-2 | 2021 |
Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Topics: Adult; Aged; Biomarkers; Ceramides; COVID-19; Female; Hospitalization; Humans; Kynurenine; Male; Met | 2021 |
Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.
Topics: Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cytokines; Epithelial Cells; Inflammation; Intes | 2021 |